US States' attempts to regulate pharmacy benefit managers are running into federal law, reviving a dispute over who has authority over companies that manage drug benefits for most Americans, Axios reports

The ongoing clash between US states and federal law regarding the regulation of pharmacy benefit managers (PBMs) highlights the complexities in the healthcare system.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Germany sells EUR 2.503bln vs exp. EUR 3.0bln 1.25% 2048, 0.00% 2052 and 2.90% 2056 Bund

Apple (AAPL) is to adopt OLED across its tablet line up, ex-standard model, ET news reports; Samsung (005930 KS) is expected to begin mass production of OLEDs from end-2026/January-2027

US States' attempts to regulate pharmacy benefit managers are running into federal law, reviving a dispute over who has authority over companies that manage drug benefits for most Americans, Axios reports

US VP Vance will head to Iowa later this month to host a pair of events ahead of the fall midterms, Axios reports

An Indian trade delegation will visit the US from April 20–22nd for trade deal talks, Indian trade official says

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Axios says the conflict centres on states seeking to curb these intermediaries while federal law governs employer health plans.
Context

As states attempt to exert more control over these intermediaries that manage drug benefits, the federal governance of employer health plans complicates this landscape. This could have broader implications for healthcare costs and market dynamics, potentially affecting equities tied to the healthcare sector.

Related headlines

The whole workspace, free to try.

Try it free